04.01.2018
- Roche is planning to buy US group Ignyta for around $1.7 billion in an all-cash deal that will expand the Swiss group’s portfolio of cancer medicines. San Diego, California-based...
13.12.2017
- From Jan. 1, 2018, Bayer will streamline its strategic pharmaceutical research and development activities and combine them under a single unit covering the therapeutic areas...
13.11.2017
- Amid estimates that the business could be worth as much as $1.5 billion, speculation is mounting that Swiss drugmaker Novartis may be planning to sell its dermatology generics arm...
02.11.2017
- UK-based Concept Life Sciences, an integrated drug discovery, development and analytical services company, has acquired Scottish contract research organization (CRO) Aquila...
22.03.2017
- The US Food and Drug Administration (FDA) has approved Novartis’ new drug Kisqali (ribociclib) as an initial treatment for postmenopausal women with a type of metastatic breast...
12.01.2017
- French drugmaker Ipsen has signed a definitive agreement to buy the global oncology assets of US-based Merrimack Pharmaceuticals in a deal worth potentially more than $1 billion...
08.09.2016
- Peptides in pharmaceutical development have traveled a rough road. It took a long time for these small proteins to emerge as a basis for new medical products. This has become...
19.05.2016
- Swiss drugmaker Novartis has announced plans to split its Pharmaceutical division into two business units, Novartis Pharmaceutical and Novartis Oncology. The first-mentioned will...
